ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Short Interest Up 98.2% in March

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) saw a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 55,700 shares, an increase of 98.2% from the February 29th total of 28,100 shares. Based on an average trading volume of 41,800 shares, the days-to-cover ratio is presently 1.3 days.

Institutional Investors Weigh In On ProShares Ultra Nasdaq Biotechnology

Large investors have recently bought and sold shares of the company. IMC Chicago LLC acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter worth approximately $2,435,000. Jane Street Group LLC acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 4th quarter worth approximately $829,000. Toth Financial Advisory Corp boosted its holdings in shares of ProShares Ultra Nasdaq Biotechnology by 17.3% during the 4th quarter. Toth Financial Advisory Corp now owns 11,241 shares of the exchange traded fund’s stock worth $641,000 after purchasing an additional 1,655 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of ProShares Ultra Nasdaq Biotechnology by 523.9% during the 3rd quarter. Tower Research Capital LLC TRC now owns 6,457 shares of the exchange traded fund’s stock worth $310,000 after purchasing an additional 5,422 shares during the last quarter. Finally, Walleye Capital LLC acquired a new position in shares of ProShares Ultra Nasdaq Biotechnology during the 1st quarter worth approximately $275,000.

ProShares Ultra Nasdaq Biotechnology Stock Performance

Shares of BIB stock traded down $0.55 on Thursday, hitting $57.54. The company had a trading volume of 34,738 shares, compared to its average volume of 43,182. ProShares Ultra Nasdaq Biotechnology has a twelve month low of $40.10 and a twelve month high of $62.45. The company has a 50-day moving average price of $57.70 and a 200-day moving average price of $52.10.

ProShares Ultra Nasdaq Biotechnology Announces Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, March 27th. Shareholders of record on Thursday, March 21st were paid a dividend of $0.0403 per share. The ex-dividend date of this dividend was Wednesday, March 20th.

ProShares Ultra Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.